Data / Form D filings / Compound Holdings I, LLC
Compound Holdings I, LLC: Form D filing
Compound Holdings I, LLC, a pharmaceuticals company in Chicago, IL, filed a Form D with the SEC in 2014. The latest, on February 24, 2014, reports $412 million sold of a $412 million offering to 178 investors.
Find out what Compound Holdings I, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- THREE FIRST NATIONAL PLAZA, SUITE 4600, Chicago, IL, 60602
- Phone
- (908) 238-6600
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1600837
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 24, 2014 | New notice | $412,000,000 | $412,000,000 | $0 | 178 | Feb 12, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Elizabeth Betten | Director | |
| Scott Charles | Executive Officer | |
| William Scheinler | Executive Officer | |
| Stephen Ross | Executive Officer | |
| Lien-Lung Sheu | Executive Officer | |
| Nicholas Alexos | Director | |
| Joseph Stauffer | Executive Officer | |
| Jason Shideler | Director | |
| Anatasios Konidaris | Executive Officer | |
| Daniel Tasse | Executive Officer, Director | |
| Michael Adasczik | Executive Officer | |
| Douglas Greene | Executive Officer | |
| Jonathan Provoost | Executive Officer | |
| Matthew Bennett | Executive Officer | |
| James Briggs | Executive Officer | |
| Timothy Sullivan | Director | |
| Matthew Holt | Director |
Every Form D from the week of Feb 24, 2014 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Compound Holdings I, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.